Literature DB >> 17053803

Clonal evolution of lymphoblastoid cell lines.

Julie L Ryan1, William K Kaufmann, Nancy Raab-Traub, Stephen E Oglesbee, Lisa A Carey, Margaret L Gulley.   

Abstract

Lymphoblastoid cell lines represent Epstein-Barr virus (EBV)-immortalized B lymphocytes, which are typically prepared by in vitro culture of normal blood cells. In this study, we evaluated the kinetics of clonal evolution in lymphoblastoid cell lines (LCLs) established from five different donors. Immunoglobulin heavy chain (IGH) and T-cell receptor gamma (TRG) gene rearrangements were tracked over time using PCR, while EBV clonality was tracked using Southern blot analysis of the viral terminal repeat fragment. All five cultures evolved towards monoclonal B cells within 8 weeks, while T lymphocytes disappeared over the same period. No significant association was found between the rapidity of clonal emergence and either the proliferation rate or the size of the EBV terminal repeat fragment, suggesting the random nature of clonal selection. Our results suggest that EBV-driven B lymphocytes rapidly progress from polyclonal to virtually monoclonal, which has implications for the pace at which lymphoma might evolve in vivo. In addition, our findings indicate that established lymphobastoid cell lines are not an ideal 'normal control' for human B lymphocytes because they do not represent the spectrum of polyclonal B cells found in healthy humans; instead, they primarily represent the progeny of a single B lymphocyte.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17053803     DOI: 10.1038/labinvest.3700472

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  16 in total

1.  Direct sequencing and characterization of a clinical isolate of Epstein-Barr virus from nasopharyngeal carcinoma tissue by using next-generation sequencing technology.

Authors:  Pan Liu; Xiaodong Fang; Zizhen Feng; Yun-Miao Guo; Rou-Jun Peng; Tengfei Liu; Zhiyong Huang; Yue Feng; Xiaoqing Sun; Zhiqiang Xiong; Xiaosen Guo; Sha-Sha Pang; Bo Wang; Xiaojuan Lv; Fu-Tuo Feng; Da-Jiang Li; Li-Zhen Chen; Qi-Sheng Feng; Wen-Lin Huang; Mu-Sheng Zeng; Jin-Xin Bei; Yong Zhang; Yi-Xin Zeng
Journal:  J Virol       Date:  2011-08-31       Impact factor: 5.103

Review 2.  Using Epstein-Barr viral load assays to diagnose, monitor, and prevent posttransplant lymphoproliferative disorder.

Authors:  Margaret L Gulley; Weihua Tang
Journal:  Clin Microbiol Rev       Date:  2010-04       Impact factor: 26.132

3.  Large C9orf72 hexanucleotide repeat expansions are seen in multiple neurodegenerative syndromes and are more frequent than expected in the UK population.

Authors:  Jon Beck; Mark Poulter; Davina Hensman; Jonathan D Rohrer; Colin J Mahoney; Gary Adamson; Tracy Campbell; James Uphill; Aaron Borg; Pietro Fratta; Richard W Orrell; Andrea Malaspina; James Rowe; Jeremy Brown; John Hodges; Katie Sidle; James M Polke; Henry Houlden; Jonathan M Schott; Nick C Fox; Martin N Rossor; Sarah J Tabrizi; Adrian M Isaacs; John Hardy; Jason D Warren; John Collinge; Simon Mead
Journal:  Am J Hum Genet       Date:  2013-02-21       Impact factor: 11.025

4.  Mitochondrial DNA mutations in pancreatic cancer.

Authors:  Keyanoosh Kassauei; Nils Habbe; Michael E Mullendore; Collins A Karikari; Anirban Maitra; Georg Feldmann
Journal:  Int J Gastrointest Cancer       Date:  2006

5.  Epstein-Barr virus BamHI W repeat number limits EBNA2/EBNA-LP coexpression in newly infected B cells and the efficiency of B-cell transformation: a rationale for the multiple W repeats in wild-type virus strains.

Authors:  Rosemary J Tierney; Kuan-Yu Kao; Jasdeep K Nagra; Alan B Rickinson
Journal:  J Virol       Date:  2011-09-28       Impact factor: 5.103

6.  Genome-wide analysis of wild-type Epstein-Barr virus genomes derived from healthy individuals of the 1,000 Genomes Project.

Authors:  Gabriel Santpere; Fleur Darre; Soledad Blanco; Antonio Alcami; Pablo Villoslada; M Mar Albà; Arcadi Navarro
Journal:  Genome Biol Evol       Date:  2014-04       Impact factor: 3.416

7.  Extent of differential allelic expression of candidate breast cancer genes is similar in blood and breast.

Authors:  Ana-Teresa Maia; Inmaculada Spiteri; Alvin J X Lee; Martin O'Reilly; Linda Jones; Carlos Caldas; Bruce A J Ponder
Journal:  Breast Cancer Res       Date:  2009-12-10       Impact factor: 6.466

8.  Epstein-Barr virus infection of naïve B cells in vitro frequently selects clones with mutated immunoglobulin genotypes: implications for virus biology.

Authors:  Emily Heath; Noelia Begue-Pastor; Sridhar Chaganti; Debbie Croom-Carter; Claire Shannon-Lowe; Dieter Kube; Regina Feederle; Henri-Jacques Delecluse; Alan B Rickinson; Andrew I Bell
Journal:  PLoS Pathog       Date:  2012-05-10       Impact factor: 6.823

9.  Clinical spectrum of females with HCCS mutation: from no clinical signs to a neonatal lethal form of the microphthalmia with linear skin defects (MLS) syndrome.

Authors:  Vanessa A van Rahden; Isabella Rau; Sigrid Fuchs; Friederike K Kosyna; Hiram Larangeira de Almeida; Helen Fryssira; Bertrand Isidor; Anna Jauch; Madeleine Joubert; Augusta M A Lachmeijer; Christiane Zweier; Ute Moog; Kerstin Kutsche
Journal:  Orphanet J Rare Dis       Date:  2014-04-15       Impact factor: 4.123

10.  Detecting, quantifying, and discriminating the mechanism of mosaic chromosomal aneuploidies using MAD-seq.

Authors:  Yu Kong; Esther R Berko; Anthony Marcketta; Shahina B Maqbool; Claudia A Simões-Pires; David F Kronn; Kenny Q Ye; Masako Suzuki; Adam Auton; John M Greally
Journal:  Genome Res       Date:  2018-05-17       Impact factor: 9.043

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.